Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Revenue (2023)

Sagimet Biosciences has reported Revenue over the past 1 years, most recently at $2.0 million for Q3 2023.

  • Quarterly results put Revenue at $2.0 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was $2.0 million (changed N/A YoY), and the annual figure for FY2023 was $2.0 million, changed.
  • Revenue for Q3 2023 was $2.0 million at Sagimet Biosciences.
  • Over the last five years, Revenue for SGMT hit a ceiling of $2.0 million in Q3 2023 and a floor of $2.0 million in Q3 2023.